These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33394316)

  • 1. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).
    Brooks JP; Rice AJ; Ji W; Lanahan SM; Konstantino M; Dara J; Hershfield MS; Cruickshank A; Dokmeci E; Lakhani S; Lucas CL
    J Clin Immunol; 2021 Apr; 41(3):680-683. PubMed ID: 33394316
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
    Hsu AP; West RR; Calvo KR; Cuellar-Rodriguez J; Parta M; Kelly SJ; Ganson NJ; Hershfield MS; Holland SM; Hickstein DD
    J Allergy Clin Immunol; 2016 Aug; 138(2):628-630.e2. PubMed ID: 27130863
    [No Abstract]   [Full Text] [Related]  

  • 3. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2.
    Le Voyer T; Boutboul D; Ledoux-Pilon A; de Fontbrune FS; Boursier G; Latour S; Le Guenno G
    J Clin Immunol; 2020 Aug; 40(6):948-953. PubMed ID: 32643137
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
    Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
    J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
    [No Abstract]   [Full Text] [Related]  

  • 6. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.
    Lee PY; Huang Y; Zhou Q; Schnappauf O; Hershfield MS; Li Y; Ganson NJ; Sampaio Moura N; Delmonte OM; Stone SS; Rivkin MJ; Pai SY; Lyons T; Sundel RP; Hsu VW; Notarangelo LD; Aksentijevich I; Nigrovic PA
    J Allergy Clin Immunol; 2018 Oct; 142(4):1363-1365.e8. PubMed ID: 29936104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
    Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
    J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.
    Maccora I; Frongia I; Azzari C; Ricci S; Cimaz R; Simonini G
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):146. PubMed ID: 30148442
    [No Abstract]   [Full Text] [Related]  

  • 9. ADA2 deficiency due to a novel structural variation in 22q11.1.
    Grossi A; Cusano R; Rusmini M; Penco F; Schena F; Podda RA; Caorsi R; Gattorno M; Uva P; Ceccherini I
    Clin Genet; 2019 Jun; 95(6):732-733. PubMed ID: 30920658
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.
    Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I
    J Clin Immunol; 2021 Nov; 41(8):1915-1935. PubMed ID: 34657246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
    Hashem H; Egler R; Dalal J
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.
    Michniacki TF; Hannibal M; Ross CW; Frame DG; DuVall AS; Khoriaty R; Vander Lugt MT; Walkovich KJ
    J Clin Immunol; 2018 Feb; 38(2):166-173. PubMed ID: 29411230
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of deficiency of adenosine deaminase 2 caused by CECR1 mutation with myeloablative hematopoietic stem cell transplantation].
    Song XC; Zhou F
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):509-511. PubMed ID: 32521966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance.
    Schnappauf O; Zhou Q; Moura NS; Ombrello AK; Michael DG; Deuitch N; Barron K; Stone DL; Hoffmann P; Hershfield M; Applegate C; Bjornsson HT; Beck DB; Witmer PD; Sobreira N; Wohler E; Chiorini JA; Center TAG; Dalgard CL; Center NIS; Kastner DL; Aksentijevich I
    J Clin Immunol; 2020 Aug; 40(6):917-926. PubMed ID: 32638197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ADA2 Compound Heterozygous Mutations Resulting in Deficiency of Adenosine Deaminase 2 in a Pair of Siblings.
    Guo L; Wang J; Yang X; Zheng R; Deuitch N; Tao P; Zhou Q
    J Clin Immunol; 2021 May; 41(4):837-842. PubMed ID: 33517505
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole Exome Sequencing Reveals Pathogenic Variants in ADA2 and FAS Causing DADA2 and ALPS.
    Ahn TS; ; ; Kohn LA
    J Clin Immunol; 2023 Aug; 43(6):1147-1151. PubMed ID: 37178281
    [No Abstract]   [Full Text] [Related]  

  • 17. ADA2 deficiency in a patient with Noonan syndrome-like disorder with loose anagen hair: The co-occurrence of two rare syndromes.
    Akgun-Dogan O; Simsek-Kiper PO; Taskiran E; Lissewski C; Brinkmann J; Schanze D; Göçmen R; Cagdas D; Bilginer Y; Utine GE; Zenker M; Ozen S; Tezcan İ; Alikasifoglu M; Boduroğlu K
    Am J Med Genet A; 2019 Dec; 179(12):2474-2480. PubMed ID: 31584751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.
    Kendall JL; Springer JM
    Curr Rheumatol Rep; 2020 Aug; 22(10):64. PubMed ID: 32845415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation.
    Nihira H; Izawa K; Ito M; Umebayashi H; Okano T; Kajikawa S; Nanishi E; Keino D; Murakami K; Isa-Nishitani M; Shiba T; Honda Y; Hijikata A; Yasu T; Kubota T; Hasegawa Y; Kawashima Y; Nakano N; Takada H; Ohga S; Heike T; Takita J; Ohara O; Takei S; Takahashi M; Kanegane H; Morio T; Iwaki-Egawa S; Sasahara Y; Nishikomori R; Yasumi T
    J Allergy Clin Immunol; 2021 Aug; 148(2):550-562. PubMed ID: 33529688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.
    Gardner LS; Vaughan L; Avery DT; Meyts I; Ma CS; Tangye SG; Varikatt W; Lin MW
    J Clin Immunol; 2024 May; 44(5):118. PubMed ID: 38758417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.